Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IGR-C82H3 | Cynomolgus | Biotinylated Cynomolgus IGF-I R / CD221 Protein, His Tag (MALS verified) |  |
|
|
| IGR-M5253 | Mouse | Mouse IGF-I R / CD221 Protein, Fc Tag |  |
|
|
| CNIH-ATP102 | Human | NIH-3T3/Human IGF-1 R Stable Cell Line Development Service | |||
| IGR-H5253 | Human | Human IGF-I R / CD221 Protein, Fc Tag |  |
|
|
| IGR-H82E3 | Human | Biotinylated Human IGF-I R / CD221 Protein, His,Avitag™ |  |
|
|
| IGR-H5229 | Human | Human IGF-I R / CD221 Protein, His Tag (MALS verified) |  |
|
|
| IGR-C5225 | Cynomolgus | Cynomolgus IGF-I R / CD221 Protein, His Tag (MALS verified) |  |
|
|
| IGR-R5224 | Rat | Rat IGF-I R / CD221 Protein, His Tag (MALS verified) |  |
|
|
| IGR-M5223 | Mouse | Mouse IGF-I R / CD221 Protein, His Tag |  |
|
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Mecasermin (Astellas/OrphanPacific) | Approved | Astellas Pharma Inc | Somazon | Japan | Growth hormone deficiency; Diabetes Mellitus, Lipoatrophic; Dwarfism | null | 1994-10-05 | Diabetes Mellitus, Lipoatrophic; Heart Failure; Myocardial Infarction; Multiple Sclerosis; HIV-Associated Lipodystrophy Syndrome; Dwarfism; Growth hormone deficiency | Details | |
| Mecasermin (Ipsen) | FK-780; IGF-1; MKN-031; rhIGF-I (Ipsen) | Approved | Genentech Inc | Increlex | United States | Failure to Thrive | Ipsen Inc | 2005-08-30 | Failure to Thrive; Autism Spectrum Disorder; Phelan-McDermid syndrome; X-Linked Combined Immunodeficiency Diseases; Growth Disorders; Laron Syndrome | Details |
| Brigatinib | AP-26113 | Approved | Ariad Pharmaceuticals Inc | Alunbrig, ALUNBRIG | United States | Carcinoma, Non-Small-Cell Lung | Takeda Pharmaceuticals USA Inc | 2017-04-28 | Solid tumours; Ependymoma; Carcinoma; Neoplasms; Neurofibromatosis 2; Myofibroma; Lymphoma, Large-Cell, Anaplastic; Granuloma, Plasma Cell; Lung Neoplasms; Brain metastases; Carcinoma, Non-Small-Cell Lung; Sarcoma, Kaposi; Neurilemmoma; Neuroma, Acoustic; Meningioma | Details |
| IGF-1 (Biogen/Pharmacia & Upjohn) | Approved | Biogen Inc, Pharmacia & Upjohn | Igef | Sweden | Dwarfism | null | 1994-01-01 | Dwarfism | Details | |
| Ceritinib | LDK-378; NVP-LDK378; NVP-LDK378-NX | Approved | Novartis Pharma Ag | 赞可达, Zykadia | EU | Carcinoma, Non-Small-Cell Lung | Novartis Europharm Ltd | 2014-04-29 | Hepatic Insufficiency; Adenocarcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Brain metastases; Esophageal adenocarcinoma; Granuloma, Plasma Cell; Lymphoma, Large-Cell, Anaplastic; Thyroid Neoplasms; Hematologic Neoplasms; Colorectal Neoplasms; Cholangiocarcinoma; Neoplasms; Pancreatic Neoplasms; Glioblastoma; Thyroid Carcinoma, Anaplastic; Stomach Neoplasms | Details |
| Teprotumumab | R-1507; RG-1507; RO-4858696; HZN-001; RV-001（River Vision） | Approved | Genmab A/S, F. Hoffmann-La Roche Ltd | Tepezza | United States | Graves Ophthalmopathy | Horizon Therapeutics Ireland | 2020-01-21 | Neoplasms; Graves Ophthalmopathy; Breast Neoplasms; Sarcoma; Diabetic macular oedema; Scleroderma, Diffuse; Carcinoma, Non-Small-Cell Lung | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Veligrotug | ZB-001; VRDN-001; AVE-1642 | Phase 3 Clinical | Viridian Therapeutics Inc | Solid tumours; Graves Ophthalmopathy; Multiple Myeloma; Breast Neoplasms | Details |
| VRDN-003 | VRDN-003 | Phase 3 Clinical | Viridian Therapeutics Inc | Graves Ophthalmopathy | Details |
| Ganitumab | AMG-479 | Phase 3 Clinical | Amgen Inc | Breast Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Lymphoma; Lung Neoplasms; Rhabdomyosarcoma, Alveolar; Colorectal Neoplasms; Neuroectodermal Tumors, Primitive; Sarcoma; Prostatic Neoplasms; Solid tumours; Sarcoma, Ewing; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Carcinoid Tumor; Rhabdomyosarcoma, Embryonal; Ovarian Neoplasms; Intestinal Neoplasms; Bone metastases; Rhabdomyosarcoma | Details |
| Linsitinib | OSI-906; ASP-7487; OSI-906AA | Phase 3 Clinical | Astellas Pharma Inc, National Cancer Institute | Multiple Myeloma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Paraganglioma; Mouth Neoplasms; Lip Neoplasms; Eye Diseases; Orbital Diseases; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Exophthalmos; Carcinoma, Basosquamous; Prostatic Neoplasms; Sarcoma, Ewing; Breast Neoplasms; Adrenocortical Carcinoma; Liver Neoplasms; Graves Ophthalmopathy; Endocrine System Diseases; Hormone-Resistant Prostate Neoplasms; Skin Neoplasms; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Neoplasms; Hashimoto Disease; Head and Neck Neoplasms; Ovarian Neoplasms; Chondrosarcoma; Thyroid Diseases; Solid tumours; Carney Complex | Details |
| FPI-1434 | [225Ac]-FPI-1434; FPX-01 | Phase 2 Clinical | Fusion Pharma | Solid tumours; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Neoplasms; Adrenocortical Carcinoma; Uveal melanoma; Breast Neoplasms; Endometrial Neoplasms; Uterine Cervical Neoplasms | Details |
| Dalotuzumab | h7C-10; MK-0646; F-50-035 | Phase 2 Clinical | Pierre Fabre Group | Solid tumours; Rectal Neoplasms; Pancreatic Neoplasms; Neoplasms; Multiple Myeloma; Neuroendocrine Tumors; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung | Details |
| CT-102 | CT-102 | Phase 2 Clinical | Hangzhou Tianlong Pharmaceutical Co Ltd, Institute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences | Liver Neoplasms; Carcinoma, Hepatocellular | Details |
| Mecasermin Rinfabate | rhIGF-I/rhIGFBP-3; TAK-607; OHB-607; IGF-I/IGFBP-3; SHP-607; HGT-ROP-001 | Phase 2 Clinical | Insmed | Noonan Syndrome; Failure to Thrive; Cerebral Intraventricular Hemorrhage; Lung Diseases; Myotonic Dystrophy; Bronchopulmonary Dysplasia; Retinopathy of Prematurity; Laron Syndrome | Details |
| Insulin growth factor receptor type 1 antisense therapy (Imvax) | IGV-001 | Phase 2 Clinical | Thomas Jefferson University | Glioblastoma | Details |
| MHB018A | MHB 018A; MHB-018A | Phase 2 Clinical | Minghui Pharmaceutical (Hangzhou) Co Ltd | Graves Ophthalmopathy | Details |
| PHP-1003 | PHP-1003; PHP1003 | Phase 2 Clinical | Suzhou Pulekang Pharmaceutical Technology Co Ltd | Graves Ophthalmopathy | Details |
| Lonigutamab | VB-421 | Phase 2 Clinical | Pierre Fabre Group | Graves Ophthalmopathy | Details |
| Cixutumumab | A-12; IMC-A12; LY-3012217; NSC-742460 | Phase 2 Clinical | Eli Lilly And Company | Chondrosarcoma, Extraskeletal Myxoid; Pinealoma; Brain Stem Neoplasms; Gliosarcoma; Breast Neoplasms; Gastrinoma; Medullary thyroid cancer (MTC); Lymphoma, Mantle-Cell; Neuroblastoma; Adenocarcinoma, Bronchiolo-Alveolar; Osteosarcoma; Retinoblastoma; Neurofibrosarcoma; Sarcoma; Sarcoma, Ewing; Prostatic Neoplasms; Glucagonoma; Mesothelioma; Glioma; Adenocarcinoma; Melanoma; Paraganglioma; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms, Male; Carcinoma, Hepatocellular; Neuroectodermal Tumors, Primitive, Peripheral; Carcinoma, Neuroendocrine; Neuroendocrine Tumors; Esophageal Squamous Cell Carcinoma; Hemangiopericytoma; Esophageal adenocarcinoma; Sarcoma, Alveolar Soft Part; Lung Neoplasms; Rhabdomyosarcoma, Alveolar; Metastatic breast cancer; Colorectal Neoplasms; Hepatoblastoma; Stomach Neoplasms; Mesenchymoma; Rectal Neoplasms; Carcinoma, Merkel Cell; Esophageal Neoplasms; Insulinoma; Squamous Cell Carcinoma of Head and Neck; Rhabdomyosarcoma, Embryonal; Carcinoma; Desmoplastic Small Round Cell Tumor; Hema | Details |
| Picropodophyllin | PPP; AXL-1717; NSC-36407 | Phase 2 Clinical | Axelar Ab | Astrocytoma; Carcinoma, Non-Small-Cell Lung | Details |
| NNC0268-0965 | NNC0268-0965 | Phase 1 Clinical | Novo Nordisk A/S | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | Details |
| IGF-1 receptor oligodeoxynucleotide-based immunotherapy (Thomas Jefferson University) | Phase 1 Clinical | Sidney Kimmel Cancer Center | Glioma | Details | |
| Insulin-Like Growth Factor 1 (Wright State Physicians) | Phase 1 Clinical | Wright State Physicians | Nasolabial fold wrinkles; Healthy Aging; Burns; Sunburn | Details | |
| SAR-446159 | ABL-301; SAR-446159 | Phase 1 Clinical | Abl Bio Inc | Parkinson Disease | Details |
| VRDN-002 | VRDN-002 | Phase 1 Clinical | Viridian Therapeutics Inc | Graves Ophthalmopathy | Details |
| LX-101 (Lirum Therapeutics) | 765IGF-MTX; IGF/MTX | Phase 1 Clinical | Lirum Therapeutics Inc | Head and Neck Neoplasms; Anemia, Refractory, with Excess of Blasts; Neoplasms; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Graves Ophthalmopathy; Brain Neoplasms; Breast Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Gastrointestinal Neoplasms; Melanoma | Details |
| ZB-011 | ZB-011; ZB011 | Phase 1 Clinical | Viridian Therapeutics Inc | Graves Ophthalmopathy | Details |
| Teprotumumab biosimilar(Boxiao Bio-pharma) | Phase 1 Clinical | Zhejiang Boxiao Bio-pharmaceutical Co Ltd | Graves Ophthalmopathy | Details | |
| 124I-CPD-1023-figitumumab | 124I-CPD-1028; 125I-CPD-1028; CPD-1028-[124I]; CPD-1028-[125I]; FPX-1028 | Phase 1 Clinical | Fusion Pharma | Neoplasms | Details |
| ALTSuLIN | Clinical | Diabetes Mellitus, Type 1; Laron Syndrome | Details |
This web search service is supported by Google Inc.
A-Z
